Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutation

Authors:
  • FMFrederick J Meyers
    Frederick J Meyers
  • TMTim R Miller
    Tim R Miller
  • SWStephen G Williams
    Stephen G Williams
  • RGRegina Gandour-Edwards
    Regina Gandour-Edwards
  • RWRalph W Devere White
    Ralph W Devere White

Abstract
No abstract available

This publication has 20 references indexed in Scilit: